Oliver Stötzer

1.7k total citations
26 papers, 433 citations indexed

About

Oliver Stötzer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Oliver Stötzer has authored 26 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Oliver Stötzer's work include Cancer Genomics and Diagnostics (5 papers), Advanced Breast Cancer Therapies (4 papers) and Cancer Treatment and Pharmacology (4 papers). Oliver Stötzer is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Advanced Breast Cancer Therapies (4 papers) and Cancer Treatment and Pharmacology (4 papers). Oliver Stötzer collaborates with scholars based in Germany, Switzerland and Belgium. Oliver Stötzer's co-authors include Stefan Holdenrieder, Dorothea Nagel, Debora M.I. Fersching, W. Wilmanns, Barbara Siegele, Bernd Schmidt, Gloria Leszinski, Michael Fleischhacker, Sabine Weickmann and Frank Gieseler and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Oliver Stötzer

26 papers receiving 416 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Oliver Stötzer 214 187 155 81 74 26 433
Petra Martin 201 0.9× 96 0.5× 140 0.9× 161 2.0× 33 0.4× 32 448
Xuewei Zhuang 147 0.7× 123 0.7× 201 1.3× 64 0.8× 44 0.6× 26 460
Maria Cristina Villarroel 165 0.8× 114 0.6× 111 0.7× 47 0.6× 36 0.5× 5 326
Burcu Çakar 195 0.9× 108 0.6× 137 0.9× 85 1.0× 39 0.5× 49 434
Anand Pathak 134 0.6× 53 0.3× 153 1.0× 40 0.5× 39 0.5× 25 395
Rosa Gallego 215 1.0× 117 0.6× 136 0.9× 58 0.7× 48 0.6× 25 358
J Mansi 147 0.7× 71 0.4× 108 0.7× 28 0.3× 40 0.5× 18 328
İbrahim Petekkaya 261 1.2× 121 0.6× 111 0.7× 83 1.0× 32 0.4× 24 382
Kathryn S. McKee 187 0.9× 74 0.4× 192 1.2× 119 1.5× 26 0.4× 12 457

Countries citing papers authored by Oliver Stötzer

Since Specialization
Citations

This map shows the geographic impact of Oliver Stötzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Stötzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Stötzer more than expected).

Fields of papers citing papers by Oliver Stötzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Stötzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Stötzer. The network helps show where Oliver Stötzer may publish in the future.

Co-authorship network of co-authors of Oliver Stötzer

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Stötzer. A scholar is included among the top collaborators of Oliver Stötzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Stötzer. Oliver Stötzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lüftner, Diana, Florian Schuetz, Andreas Schneeweiß, et al.. (2024). Efficacy and safety of everolimus plus exemestane in patients with hormone receptor‐positive, HER‐2‐negative advanced breast cancer: Results from the open‐label, multicentre, non‐interventional BRAWO study. International Journal of Cancer. 155(1). 128–138. 1 indexed citations
2.
Wimberger, Pauline, Jens‐Uwe Blohmer, Petra Krabisch, et al.. (2023). The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy. Breast Cancer Research. 25(1). 32–32. 6 indexed citations
3.
4.
5.
6.
Meißner, Karin, et al.. (2019). Individual Factors Contributing to Nausea in First-Time Chemotherapy Patients: A Prospective Cohort Study. Frontiers in Pharmacology. 10. 410–410. 10 indexed citations
7.
8.
Stötzer, Oliver, et al.. (2013). Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy. Clinica Chimica Acta. 425. 206–211. 39 indexed citations
9.
Stötzer, Oliver, et al.. (2013). Plasma DNA integrity indicates response to neoadjuvant chemotherapy in patients with locally confined breast cancer. International Journal of Clinical Pharmacology and Therapeutics. 51(1). 59–62. 8 indexed citations
10.
Stötzer, Oliver, et al.. (2013). Diagnostic relevance of plasma DNA and DNA integrity for breast cancer. Tumor Biology. 35(2). 1183–1191. 42 indexed citations
11.
Weigand, Luise, Sabine Mall, Richard Klar, et al.. (2012). Isolation of human MHC class II‐restricted T cell receptors from the autologous T‐cell repertoire with potent anti‐leukaemic reactivity. Immunology. 137(3). 226–238. 10 indexed citations
12.
Fleischhacker, Michael, Bernd Schmidt, Sabine Weickmann, et al.. (2011). Methods for isolation of cell-free plasma DNA strongly affect DNA yield. Clinica Chimica Acta. 412(23-24). 2085–2088. 93 indexed citations
13.
Boeck, Stefan, K. Weigang-Köhler, Martin Fuchs, et al.. (2007). Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial. Annals of Oncology. 18(4). 745–751. 59 indexed citations
14.
Pihusch, Rudolf, Ernst Holler, Dieter Mühlbayer, et al.. (2002). The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation. Bone Marrow Transplantation. 30(6). 347–354. 48 indexed citations
15.
Schmid, Christoph, et al.. (2002). Dosisreduzierte Konditionierung vor allogener Stammzelltransplantation. DMW - Deutsche Medizinische Wochenschrift. 127(42). 2186–2192. 5 indexed citations
16.
Stötzer, Oliver, Michael Schleuning, Georg Ledderose, W. Hiddemann, & Hans-Jochen Kölb. (2001). Allogene Transplantation maligner Lymphome. DMW - Deutsche Medizinische Wochenschrift. 126(39). 1062–1069. 1 indexed citations
17.
Nuessler, V., et al.. (1999). Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines. Leukemia. 13(11). 1864–1872. 42 indexed citations
18.
19.
Munker, Reinhold, et al.. (1996). Autoantibodies against p53 are not increased in human ascites and pleural effusions. Cancer Immunology Immunotherapy. 42(3). 200–201. 6 indexed citations
20.
Munker, Reinhold, et al.. (1994). [Expression of transforming growth factor beta-3 (TGF-beta-3) on reactive and malignant cells in ascites and pleural effusion].. PubMed. 89(5). 248–51. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra Martin Breakdown of academic impact, for papers by Xuewei Zhuang Breakdown of academic impact, for papers by Maria Cristina Villarroel Breakdown of academic impact, for papers by Burcu Çakar Breakdown of academic impact, for papers by Anand Pathak Breakdown of academic impact, for papers by Rosa Gallego Breakdown of academic impact, for papers by J Mansi Breakdown of academic impact, for papers by İbrahim Petekkaya Breakdown of academic impact, for papers by Kathryn S. McKee
Rankless by CCL
2026